ISRAEL’S MEDICAL ACHIEVEMENTS
The gene that protects against ALS. Researchers from Ben-Gurion University have discovered the gene MIF that stops the protein superoxide dismutase (SOD1) from misfolding and then killing motor neurons, leading to ALS (Amyotrophic Lateral Sclerosis) or Lou Gehrig’s disease.
https://aabgu.org/gene-modulation-for-als-treatment/
Lupus treatment works in lower doses. (TY Atid-EDI) I reported previously (Mar 2014) about hCDR1 from Israeli biotech XTL for treating Lupus (Systemic Lupus Erythematosus – SLE). Trials have found many cases where low dosages of hCDR1 are more effective than high ones. XTL have filed new US and European patents.
http://www.prnewswire.com/news-releases/xtl-biopharmaceuticals-announces-new-patent-filing-in-us-for-lupus-drug-hcdr1-589846971.html http://lupusnewstoday.com/2016/09/08/xtl-biopharmaceuticals-granted-european-union-patent-for-lupus-drug-hcdr1
Successful trials of Tennis Elbow treatment. (TY Atid-EDI) Israel’s Collplant has reported positive results of trials of its Vergenix STR treatment for inflammation of the elbow tendon – commonly referred to as tennis elbow. Most of the 40 patients reported less pain and disability – far better than those just on steroids.
http://www.prnewswire.com/news-releases/collplant-reports-positive-final-extended-clinical-trial-results-with-vergenixstr-for-treatment-of-tendinopathy-590460101.html http://www.collplant.com/
Keeping a watch on Huntington’s disease. Israel’s Teva is to work with Intel Corp. to develop a wearable device combined with a machine learning platform to try and improve treatment for Huntington’s disease. A smartwatch and smartphone will continuously measure the severity of the motoric symptoms.
http://www.timesofisrael.com/teva-intel-join-forces-to-monitor-huntington-disease/
Predicting heart attacks and strokes. (TY Atid-EDI) I reported previously on Israel’s Zebra Medical Vision which can identify patients at early risk of osteoporosis, cardiac disease, liver disease etc. Zebra has just announced its development of two new software algorithms that predict cardiovascular events.
http://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=114881
https://www.youtube.com/watch?v=sSJYnetYBpU https://www.zebra-med.com/
A liquid biopsy for cancer. (TY Karen) An interview on ILTV Daily with Dr Alan Schwebel, President and CEO of Israel’s BioView, which I reported on previously (see here). Dr Schwebel describes Bioview’s scanning system for early detection of cancer cells and identification of the most appropriate treatment.
https://www.youtube.com/watch?v=_lzo9mhJlOw
App connects cancer sufferers. Mobile app “Belong” was developed by Israeli entrepreneurs who had lost family members to cancer. The app (iOS or Android) allows patients to share vital information whilst reducing feelings of loneliness and anxiety. It also provides tips, questions for doctors, and info on medical procedures.
http://www.timesofisrael.com/belong-aims-to-help-patients-navigate-cancers-twists-and-turns/